Off-Label Prescriptions

In the Summer 2018 edition of the Royal College of Psychiatrist’s magazine,  I N S I G H T, Professor David Baldwin, Chair of the College Psychopharmacology Committee gives advice on off-label prescribing:


The full article can be read here.

The following is an extract:

I would have expected this perspective, by a key opinion leader and Chair of the Royal College of Psychiatrists Psychopharmacology Committee, to include full details of any potential declarations of competing interests. However, it did not.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.